Integration of npy, agrp, and melanocortin signals in the hypothalamic paraventricular nucleus: Evidence of a cellular basis for the adipostat

Neuron

Volumn 24, Issue 1, 1999, Pages 155-163

  Cowley, Michael A ^a   Pronchuk, Nina ^b   Fan, Wei ^a   Dinulescu, Daniela M ^a   Colmers, William F ^b   Cone, Roger D ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE INHIBITOR; MELANOCORTIN; NEUROPEPTIDE Y;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALORIC INTAKE; CONTROLLED STUDY; ENERGY BALANCE; ENERGY EXPENDITURE; FEEDING BEHAVIOR; HORMONAL REGULATION; HORMONE INHIBITION; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; LIPID STORAGE; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0033200153     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)80829-6     Document Type: Article

References (52)

1. Billington, C.J., Briggs, J.E., Grace, M., and Levine, A.S. (1991). Effects of intracerebroventricular administration of neuropeptide Y on energy metabolism. Am. J. Physiol. 260, R321-R327.
2. Blanton, M.G., Lo Turco, J.J., and Kriegstein, A.R. (1989). Whole cell recording from neurons in slices of reptilian and mammalian cerebral cortex. J. Neurosci. Methods 30, 203-210.
3. Broberger, C., Johansson, C., Schalling, M., and Hokfelt, T. (1998). The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc. Natl. Acad. Sci. USA 95, 15043-15048.
4. Bultman, S.J., Michaud, E.J., and Woychik, R.P. (1992). Molecular characterization of the mouse agouti locus. Cell 71, 1195-1204.
5. Cheung, C.C., Clifton, D.K., and Steiner, R.A. (1997). Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 138, 4489-4492.
6. Chieng, B., and Williams, J.T. (1998). Increased opioid inhibition of GABA release in nucleus accumbens during morphine withdrawal. J. Neurosci. 18, 7033-7039.
7. Colmers, W.F., and Bleakman, D. (1994). Neuropeptide Y effects on the electrical properties of neurons. Trends Neurosci. 17, 373-379.
8. Cone, R.D., Lu, D., Chen, W., Koppula, S., Vage, D.I., Klungland, H., Boston, B., Orth, D.N., Pouton, C., and Kesterson, R.A. (1996). The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. Rec. Prog. Hormone Res. 51, 287-318.
9. Egawa, M., Yoshimatsu, H., and Bray, G.A. (1991). Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue in rats. Am. J. Physiol. 260, R328-R334.
10. Elmquist, J.K., Elias, C.F., and Saper, C.B. (1999). From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22, 221-232.
11. Erickson, J.C., Clegg, K.E., and Palmiter, R.D. (1996). Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381, 415-418.
12. Fan, W., Boston, B.A., Kesterson, R.A., Hruby, V.J., and Cone, R.D. (1997). Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385, 165-168.
13. Fong, T.M., Mao, C., MacNeil, C., Kalyani, R., Smith, T., Weinberg, D., Tota, M.R., and Van der Ploeg, L.H. (1997). ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors. Biochem. Biophys. Res. Commun. 237, 629-631.
14. Giraudo, S.Q., Billington, C.J., and Levine, A.S. (1998). Feeding effects of hypothalamic injection of melanocortin 4 receptor ligands. Brain Res. 809, 302-306.
15. Glaum, S.R., Hara, M., Bindokas, V.P., Lee, C.C., Polonsky, K.S., Bell, G.I., and Miller, R.J. (1997). Leptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus. Mol. Pharmacol. 50, 230-235.
16. Graham, M., Shuttre, J.R., Sarmiento, U., Sarosi, I., and Stark, K.L. (1997). Overexpression of Agrt leads to obesity in transgenic mice. Nat. Genet. 17, 273-274.
17. Gu, G.B., and Simerly, R.B. (1997). Projections of the sexually dimorphic anteroventral periventricular nucleus in the female rat. J. Comp. Neurol. 384, 142-164.
18. Häkansson, M.-L., Hulting, A.-L., and Meister, B. (1996). Expression of leptin receptor mRNA in the hypothalamic arcuate nucleus -relationship with NPY neurons. Neuroreport 7, 3087-3092.
19. Haskell-Luevano, C., Chen, P., Li, C., Chang, K., Smith, M.S., Cameron, J.L., and Cone, R.D. (1999). Characterization of the neuroanatomical distribution of agouti-related protein (AGRP) IR in the rhesus monkey and the rat. Endocrinology 140, 1408-1415.
20. Haynes, W.G., Morgan, D.A., Djalali, A., Sivitz, W.I., and Mark, A.L. (1999). Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 33, 542-547.
21. Herzog, H., Hort, Y.J., Ball, H.J., Hayes, G., Shine, J., and Selbie, L.A. (1992). Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc. Natl. Acad. Sci. USA 89, 5794-5798.
22. Hoffman, N.W., Tasker, J.G., and Dudek, F.E. (1991). Immunohistochemical differentiation of electrophysiologically defined neuronal populations in the region of the rat hypothalamic paraventricular nucleus. J. Comp. Neurol. 307, 405-416.
23. 2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J. Med. Chem. 38, 3454-3461.
24. Huszar, D., Lynch, C.A., Fairchild-Huntress, V., Dunmore, J.H., Fang, Q., Berkemeier, L.R., Gu, W., Kesterson, R.A., Boston, B.A., Cone, R.D., et al. (1997). Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88, 131-141.
25. Ingram, S.L., Vaughan, C.W., Bagley, E.E., Connor, M., and Christie, M.J. (1998). Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. J. Neurosci. 18, 10269-10276.
26. Kalra, S.P., Dube, M.G., Pu, S., Xu, B., Horvath, T.L., and Kalra, P.S. (1999). Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. 20, 68-100.
27. Kennedy, G.C. (1953). The role of depot fat in the hypothalamic control of food intake in the rat. Proc. R. Soc. Lond. B Biol. Sci. 140, 579-592.
28. Klapstein, G.J., Treherne, K.A., and Colmers, W.F. (1990). NPY: presynaptic effects in hippocampal slice in vitro are Y2 receptor-mediated but not via inhibition of adenylate cyclase. Ann. NY Acad. Sci. 611, 457-458.
29. Konda, Y., Gantz, I., DelValle, J., Shimoto, Y., Miwa, H., and Yamada, T. (1994). Interaction of dual intracellular signaling pathways activated by the melanocortin-3 receptor. J. Biol. Chem. 269, 13162-13166.
30. Krude, H., Biebermann, H., Luck, W., Horn, R., Brabant, G., and Gruters, A. (1998). Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat. Genet. 19, 155-157.
31. Larsen, P.J., Sheikh, S.P., and Mikkelsen, J.D. (1992). Osmotic regulation of neuropeptide Y and its binding sites in the magnocellular hypothalamic-neurohypophysial pathway. Brain Res. 573, 181-189.
32. Lee, W.S., Abbud, R., Hoffman, G.E., and Smith, M.S. (1993). Effects of N-methyl-D-aspartate receptor activation on cFos expression in luteinizing hormone-releasing hormone neurons in female rats. Endocrinology 133, 2248-2254.
33. McQuiston, A.R., and Colmers, W.F. (1992). Neuropeptide Y does not alter NMDA conductances in CA3 pyramidal neurons: a slice-patch study. Neurosci. Lett. 138, 261-264.
34. Mercer, J.G., Hoggard, N., Williams, L.N., Lawrence, C.B., Hannah, L.T., Morgan, P.J., and Trayhurn, P. (1996). Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J. Neuroendocrinol. 8, 733-735.
35. Mitchel, J.S., and Keesey, R.E. (1977). Defense of a lowered weight maintenance level by lateral hypothalamically lesioned rats: evidence from a restriction-refeeding regimen. Physiol. Behav. 18, 1121-1125.
36. Mountjoy, K.G., Mortrud, M.T., Low, M.J., Simerly, R.B., and Cone, R.D. (1994). Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol. Endocrinol. 8, 1298-1308.
37. Nilaver, G., Zimmerman, E.A., Defendini, R., Liotta, A.S., Krieger, D.T., and Brownstein, M.J. (1979). Adrenocorticotropin and beta-lipotropin in the hypothalamus. Localization in the same arcuate neurons by sequential immunocytochemical procedures. J. Cell Biol. 81, 50-58.
38. Obrietan, K., and van den Pol, A.N. (1996). Neuropeptide Y depresses GABA-mediated calcium transients in developing suprachiasmatic nucleus neurons: a novel form of calcium long-term depression. J. Neurosci. 16, 3521-3533.
39. Ollmann, M.M., Wilson, B.D., Yang, Y.-K., Kerns, J.A., Chen, Y., Gantz, I., and Barsh, G.S. (1997). Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278, 135-137.
40. 2+ entry. J. Neurosci. 17, 8169-8177.
41. Roselli-Rehfuss, L., Mountjoy, K.G., Robbins, L.S., Mortrud, M.T., Low, M.J., Tatro, J.B., Entwistle, M.L., Simerly, R.B., and Cone, R.D. (1993). Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc. Natl. Acad. Sci. USA 90, 8856-8860.
42. Rossi, M., Kim, M.S., Morgan, D.G., Small, C.J., Edwards, C.M., Sunter, D., Abusnana, S., Goldstone, A.P., Russell, S.H., Stanley, S.A., et al. (1998). A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology 139, 4428-4431.
43. Sawchenko, P.E., Swanson, L.W., Grzanna, R., Howe, P.R.C., Bloom, S.R., and Polak, J.M. (1985). Colocalization of neuropeptide Y IR in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J. Comp. Neurol. 247, 138-153.
44. Shutter, J.R., Graham, M., Kinsey, A.C., Scully, S., Luthy, R., and Stark, K.L. (1997). Hypothalamic expression of ART, a novel gene related to agouti, is upregulated in obese and diabetic mutant mice. Genes Dev. 11, 593-602.
45. Stanley, B.C. (1993). Neuropeptide Y in multiple hypothalamic sites controls eating behavior, endocrine and autonomic systems for body energy balance. In The Biology of Neuropeptide Y and Related Peptides, W.F. Colmers and C. Wahlestedt, eds. (Totowa: Humana Press), pp. 457-509.
46. Steffens, A.B. (1975). Influence of reversible obesity on eating behavior, blood glucose, and insulin in the rat. Am. J. Physiol. 228, 1738-1744.
47. Tomaszuk, A., Simpson, C., and Williams, G. (1996). Neuropeptide Y, the hypothalamus and the regulation of energy homeostasis. Hormone Res. 46, 53-58.
48. 2+ influx at sympathetic nerve terminals. Nature 364, 635-639.
49. Vaisse, C., Clement, K., Guy-Grand, B., and Froguel, P. (1998). A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. 20, 113-114.
50. Watson, S.J., Akil, H., Richard, C.W., and Barchas, J.D. (1978). Evidence for two separate opiate peptide neuronal systems and the coexistence of beta-lipotropin, beta-endorphin, and ACTH immunoreactivities in the same hypothalamic neurons. Nature 275, 226-228.
51. Woods, S.C., Seeley, R.J., Porte, D., Jr., and Schwartz, M.W. (1998). Signals that regulate food intake and energy homeostasis. Science 280, 1378-1382.
52. Yeo, G.S.H., Farooqi, I.S., Aminian, S., Halsall, D.J., Stanhope, R.G., and O'Rahilly, S. (1998). A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 20, 111-112.